DRKS00017068暂停不适用
A NON-INTERVENTIONAL, MULTI-CENTER, NON?RANDOMISED PATIENT REGISTRY FOR POST?MARKETING SURVEILLANCE OF MULTIPLE ORGAN DIALYSIS - EMOS - REGISTRY
ADVITOS GmbH0 个研究点目标入组 282 人开始时间: 2019年4月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 282
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Age 18 or above;
- •2. Indication for multiple organ dialysis;
- •3. Signed informed consent form to participate in the registry.
- •Note: For patients unable or unwilling to provide informed consent, anonymized (i.e. untraceable) data will be collected. For patients who were already treated with the ADVOS multi device, anonymized (i.e. untraceable) data will be collected retrospectively.
排除标准
- •No patients will be excluded.
研究者
相似试验
招募中
4 期
Safety and Effectiveness assessment of Trastuzumab emtansine of Zydus Lifesciences Ltd for the treatment of early breast cancer in Indian patients.CTRI/2023/04/051319Zydus Lifesciences Limited
Unknown
不适用
An observational study to understand usage and effect of daclatasvir use with sofosbuvir for the treatment of adults with chronic hepatitis C infectionsCTRI/2017/07/009056Torrent Pharmaceuticals Ltd54
尚未招募
不适用
A study to compare the usage and safety of Teneligliptin versus Glimepiride in diabetic patients being treated with MetformiCTRI/2017/08/009262Torrent Pharmaceuticals Ltd
招募中
不适用
A Observational Study to Understand Usage and Effectiveness of Teneligliptin in Indian Patients with Type 2 Diabetes MellitusCTRI/2018/08/015457Torrent Pharmaceuticals Ltd
Unknown
不适用
An observational study to understand usage and effect of combination of ledipasvir and sofosbuvir in adult patients with Hepatitis C InfectioCTRI/2016/11/007468Torrent Pharmaceuticals Ltd88